Viewing nowHwanin Donepezil 10 mg Tablet (Donepezil Hydrochloride Monohydrate)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

MFDS item code 200805353 · Notified 2008.05.09 · Insurance code 657201230
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of symptoms associated with Alzheimer's type dementia.
○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with attention to gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually decrease, and no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg per day.
○ Children: There is no experience with use in children.
This medication contains Donepezil Hydrochloride Monohydrate as the active ingredient and is used for the treatment of symptoms associated with Alzheimer's type dementia. This medication should not be used in patients with hypersensitivity to specific ingredients or in women who are pregnant or breastfeeding. Caution is advised for patients with heart disease or cardiac conduction disorders, patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs, patients with a history of asthma or obstructive pulmonary disease, and patients with extrapyramidal disorders such as Parkinson's disease. Since this medication may slow the heart rate or cause arrhythmias, patients with heart disease should be particularly cautious. Additionally, there may be an increased risk of gastrointestinal bleeding or worsening of peptic ulcers, so monitoring for gastrointestinal symptoms is necessary. This medication may trigger bronchoconstriction, potentially worsening asthma symptoms; thus, patients with respiratory diseases should be careful. During treatment with this medication, side effects such as dizziness, nausea, vomiting, diarrhea, insomnia, muscle pain, fatigue, and headaches may occur. Rarely, severe heart problems, liver dysfunction, cerebrovascular disorders, or renal failure may arise, and if any unusual symptoms occur, immediate consultation with healthcare providers is necessary. The risk of side effects may increase when used with other medications that affect cardiac conduction, so it is essential to inform about any other medications being taken. It is recommended to avoid this medication during pregnancy or breastfeeding, especially for nursing mothers who should discontinue breastfeeding during treatment. Safety in children has not been established; therefore, it is advisable not to use this medication in children. This medication may affect driving or operating machinery, so caution is required during the initial doses or when adjusting the dosage. In cases of overdose, symptoms such as nausea, vomiting, sweating, bradycardia, hypotension, respiratory depression, and seizures may occur, necessitating immediate emergency treatment. This medication should be stored out of reach of children, and transferring it to another container may adversely affect quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1 to 30 degrees Celsius. This helps maintain the medication's effectiveness for a longer duration.
Yellow round film-coated tablet
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle, For export - 30 tablets/PTP [(10 tablets/PTP×3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.